Display options
Cite
Perry AE, Martyn-St James M, Burns L, et al. Interventions for drug-using offenders with co-occurring mental health problems. Cochrane Database Syst Rev. 2019;10:CD010901doi: 10.1002/14651858.CD010901.pub3.
Perry, A. E., Martyn-St James, M., Burns, L., Hewitt, C., Glanville, J. M., Aboaja, A., Thakkar, P., Santosh Kumar, K. M., Pearson, C., Wright, K., & Swami, S. (2019). Interventions for drug-using offenders with co-occurring mental health problems. The Cochrane database of systematic reviews, 10CD010901. https://doi.org/10.1002/14651858.CD010901.pub3
Perry, Amanda E, et al. "Interventions for drug-using offenders with co-occurring mental health problems." The Cochrane database of systematic reviews vol. 10 (2019): CD010901. doi: https://doi.org/10.1002/14651858.CD010901.pub3
Perry AE, Martyn-St James M, Burns L, Hewitt C, Glanville JM, Aboaja A, Thakkar P, Santosh Kumar KM, Pearson C, Wright K, Swami S. Interventions for drug-using offenders with co-occurring mental health problems. Cochrane Database Syst Rev. 2019 Oct 07;10:CD010901. doi: 10.1002/14651858.CD010901.pub3. Epub 2019 Oct 07. PMID: 31588993; PMCID: PMC6778977.
Copy Download .nbib Format: NLM
Share it on

Cochrane Database Syst Rev. 2019 Oct 07;10:CD010901. doi: 10.1002/14651858.CD010901.pub3. Epub 2019 Oct 07.

Interventions for drug-using offenders with co-occurring mental health problems.

The Cochrane database of systematic reviews

Amanda E Perry, Marrissa Martyn-St James, Lucy Burns, Catherine Hewitt, Julie M Glanville, Anne Aboaja, Pratish Thakkar, Keshava Murthy Santosh Kumar, Caroline Pearson, Kath Wright, Shilpi Swami

Affiliations

  1. Department of Health Sciences, University of York, Heslington, York, UK, YO105DD.

PMID: 31588993 PMCID: PMC6778977 DOI: 10.1002/14651858.CD010901.pub3

Abstract

BACKGROUND: This review represents one from a family of three reviews focusing on interventions for drug-using offenders. Many people under the care of the criminal justice system have co-occurring mental health problems and drug misuse problems; it is important to identify the most effective treatments for this vulnerable population.

OBJECTIVES: To assess the effectiveness of interventions for drug-using offenders with co-occurring mental health problems in reducing criminal activity or drug use, or both.This review addresses the following questions.• Does any treatment for drug-using offenders with co-occurring mental health problems reduce drug use?• Does any treatment for drug-using offenders with co-occurring mental health problems reduce criminal activity?• Does the treatment setting (court, community, prison/secure establishment) affect intervention outcome(s)?• Does the type of treatment affect treatment outcome(s)?

SEARCH METHODS: We searched 12 databases up to February 2019 and checked the reference lists of included studies. We contacted experts in the field for further information.

SELECTION CRITERIA: We included randomised controlled trials designed to prevent relapse of drug use and/or criminal activity among drug-using offenders with co-occurring mental health problems.

DATA COLLECTION AND ANALYSIS: We used standard methodological procedures as expected by Cochrane .

MAIN RESULTS: We included 13 studies with a total of 2606 participants. Interventions were delivered in prison (eight studies; 61%), in court (two studies; 15%), in the community (two studies; 15%), or at a medium secure hospital (one study; 8%). Main sources of bias were unclear risk of selection bias and high risk of detection bias.Four studies compared a therapeutic community intervention versus (1) treatment as usual (two studies; 266 participants), providing moderate-certainty evidence that participants who received the intervention were less likely to be involved in subsequent criminal activity (risk ratio (RR) 0.67, 95% confidence interval (CI) 0.53 to 0.84) or returned to prison (RR 0.40, 95% CI 0.24 to 0.67); (2) a cognitive-behavioural therapy (one study; 314 participants), reporting no significant reduction in self-reported drug use (RR 0.78, 95% CI 0.46 to 1.32), re-arrest for any type of crime (RR 0.69, 95% CI 0.44 to 1.09), criminal activity (RR 0.74, 95% CI 0.52 to 1.05), or drug-related crime (RR 0.87, 95% CI 0.56 to 1.36), yielding low-certainty evidence; and (3) a waiting list control (one study; 478 participants), showing a significant reduction in return to prison for those people engaging in the therapeutic community (RR 0.60, 95% CI 0.46 to 0.79), providing moderate-certainty evidence.One study (235 participants) compared a mental health treatment court with an assertive case management model versus treatment as usual, showing no significant reduction at 12 months' follow-up on an Addictive Severity Index (ASI) self-report of drug use (mean difference (MD) 0.00, 95% CI -0.03 to 0.03), conviction for a new crime (RR 1.05, 95% CI 0.90 to 1.22), or re-incarceration to jail (RR 0.79, 95% CI 0.62 to 1.01), providing low-certainty evidence.Four studies compared motivational interviewing/mindfulness and cognitive skills with relaxation therapy (one study), a waiting list control (one study), or treatment as usual (two studies). In comparison to relaxation training, one study reported narrative information on marijuana use at three-month follow-up assessment. Researchers reported a main effect < .007 with participants in the motivational interviewing group, showing fewer problems than participants in the relaxation training group, with moderate-certainty evidence. In comparison to a waiting list control, one study reported no significant reduction in self-reported drug use based on the ASI (MD -0.04, 95% CI -0.37 to 0.29) and on abstinence from drug use (RR 2.89, 95% CI 0.73 to 11.43), presenting low-certainty evidence at six months (31 participants). In comparison to treatment as usual, two studies (with 40 participants) found no significant reduction in frequency of marijuana use at three months post release (MD -1.05, 95% CI -2.39 to 0.29) nor time to first arrest (MD 0.87, 95% CI -0.12 to 1.86), along with a small reduction in frequency of re-arrest (MD -0.66, 95% CI -1.31 to -0.01) up to 36 months, yielding low-certainty evidence; the other study with 80 participants found no significant reduction in positive drug screens at 12 months (MD -0.7, 95% CI -3.5 to 2.1), providing very low-certainty evidence.Two studies reported on the use of multi-systemic therapy involving juveniles and families versus treatment as usual and adolescent substance abuse therapy. In comparing treatment as usual, researchers found no significant reduction up to seven months in drug dependence on the Drug Use Disorders Identification Test (DUDIT) score (MD -0.22, 95% CI -2.51 to 2.07) nor in arrests (RR 0.97, 95% CI 0.70 to 1.36), providing low-certainty evidence (156 participants). In comparison to an adolescent substance abuse therapy, one study (112 participants) found significant reduction in re-arrests up to 24 months (MD 0.24, 95% CI 0.76 to 0.28), based on low-certainty evidence.One study (38 participants) reported on the use of interpersonal psychotherapy in comparison to a psychoeducational intervention. Investigators found no significant reduction in self-reported drug use at three months (RR 0.67, 95% CI 0.30 to 1.50), providing very low-certainty evidence. The final study (29 participants) compared legal defence service and wrap-around social work services versus legal defence service only and found no significant reductions in the number of new offences committed at 12 months (RR 0.64, 95% CI 0.07 to 6.01), yielding very low-certainty evidence.

AUTHORS' CONCLUSIONS: Therapeutic community interventions and mental health treatment courts may help people to reduce subsequent drug use and/or criminal activity. For other interventions such as interpersonal psychotherapy, multi-systemic therapy, legal defence wrap-around services, and motivational interviewing, the evidence is more uncertain. Studies showed a high degree of variation, warranting a degree of caution in interpreting the magnitude of effect and the direction of benefit for treatment outcomes.

References

  1. Trials. 2007 Jan 08;8:1 - PubMed
  2. Am J Drug Alcohol Abuse. 2005;31(3):393-401 - PubMed
  3. Psychiatr Serv. 2016 Feb;67(2):169-75 - PubMed
  4. J Behav Health Serv Res. 2015 Oct;42(4):554 - PubMed
  5. Contemp Clin Trials. 2017 Aug;59:1-12 - PubMed
  6. Am J Addict. 2003 Jul-Sep;12(4):314-23 - PubMed
  7. Int J Drug Policy. 2018 Jan;51:42-51 - PubMed
  8. Psychiatr Serv. 2007 Jul;58(7):955-61 - PubMed
  9. J Am Acad Psychiatry Law. 2007;35(1):83-91 - PubMed
  10. Contemp Clin Trials. 2016 Jul;49:57-64 - PubMed
  11. AIDS Behav. 2013 Oct;17 Suppl 2:S156-70 - PubMed
  12. Child Youth Serv Rev. 2012 Apr 1;34(4):639-647 - PubMed
  13. J Subst Abuse Treat. 2017 Oct;81:25-34 - PubMed
  14. J Subst Abuse Treat. 1999 Dec;17(4):339-47 - PubMed
  15. J Urban Health. 2013 Oct;90(5):983-96 - PubMed
  16. Am J Addict. 2013 Sep-Oct;22(5):500-2 - PubMed
  17. Am J Public Health. 2005 Jan;95(1):131-7 - PubMed
  18. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005193 - PubMed
  19. Int Clin Psychopharmacol. 2005 Sep;20(5):253-6 - PubMed
  20. Am J Drug Alcohol Abuse. 2003;29(1):1-18 - PubMed
  21. Eval Rev. 2000 Apr;24(2):212-41 - PubMed
  22. J Clin Psychopharmacol. 2015 Oct;35(5):535-43 - PubMed
  23. Community Ment Health J. 2016 Feb;52(2):127-35 - PubMed
  24. J Subst Abuse Treat. 2015 Nov;58:25-32 - PubMed
  25. J Exp Criminol. 2011 Sep;7(3):225-253 - PubMed
  26. Curr Psychiatry Rep. 2009 Oct;11(5):370-6 - PubMed
  27. J Marital Fam Ther. 2018 Jul;44(3):483-498 - PubMed
  28. Psychiatr Serv. 1998 Apr;49(4):483-92 - PubMed
  29. Contemp Clin Trials. 2017 Feb;53:130-136 - PubMed
  30. Qual Manag Health Care. 2010 Jan-Mar;19(1):62-9 - PubMed
  31. Int J Offender Ther Comp Criminol. 2014 May;58(5):522-36 - PubMed
  32. AIDS. 2015 Apr 24;29(7):819-24 - PubMed
  33. Syst Rev. 2014 May 16;3:45 - PubMed
  34. Addiction. 2012 Sep;107(9):1650-9 - PubMed
  35. Hosp Community Psychiatry. 1989 Dec;40(12):1309-10 - PubMed
  36. Harm Reduct J. 2006 Sep 27;3:28 - PubMed
  37. Psychiatr Serv. 2014 Nov 1;65(11):1325-31 - PubMed
  38. J Subst Abuse Treat. 2017 Sep;80:59-66 - PubMed
  39. PLoS One. 2014 Mar 25;9(3):e92809 - PubMed
  40. Cochrane Database Syst Rev. 2015 Jun 02;(6):CD010901 - PubMed
  41. J Appl Behav Anal. 2008 Winter;41(4):565-77 - PubMed
  42. Addiction. 2005 Jun;100(6):820-8 - PubMed
  43. Behav Ther. 2009 Dec;40(4):325-36 - PubMed
  44. J Nerv Ment Dis. 1997 May;185(5):306-13 - PubMed
  45. Drug Alcohol Depend. 2017 Jun 1;175:164-170 - PubMed
  46. J Addict Dis. 2012;31(3):258-69 - PubMed
  47. BMC Public Health. 2017 Mar 11;17(1):246 - PubMed
  48. J Am Acad Psychiatry Law. 2008;36(3):354-9 - PubMed
  49. Behav Sci Law. 2004;22(4):477-501 - PubMed
  50. Eur Arch Psychiatry Clin Neurosci. 2012 Dec;262(8):705-24 - PubMed
  51. Int J Drug Policy. 2017 Jan;39:86-91 - PubMed
  52. J Subst Abuse Treat. 2013 Jan;44(1):78-83 - PubMed
  53. Addiction. 2002 Dec;97 Suppl 1:1-3 - PubMed
  54. Trials. 2013 Sep 24;14:309 - PubMed
  55. J Fam Psychol. 2015 Apr;29(2):232-41 - PubMed
  56. J Stud Alcohol Drugs. 2011 May;72(3):497-506 - PubMed
  57. Int J Addict. 1982 Feb;17(2):393-7 - PubMed
  58. Soc Work Public Health. 2015;30(3):225-35 - PubMed
  59. Addiction. 2014 Mar;109(3):440-9 - PubMed
  60. Lancet Psychiatry. 2015 May;2(5):422-430 - PubMed
  61. J Consult Clin Psychol. 2012 Dec;80(6):1114-20 - PubMed
  62. Int Pharmacopsychiatry. 1975;10(4):240-50 - PubMed
  63. NIDA Res Monogr. 1976 Sep;(9):93-8 - PubMed
  64. Addiction. 2017 Aug;112(8):1440-1450 - PubMed
  65. J Subst Abuse Treat. 2003 Sep;25(2):99-105 - PubMed
  66. Eval Rev. 2005 Feb;29(1):42-64 - PubMed
  67. J Behav Health Serv Res. 2015 Apr;42(2):172-90 - PubMed
  68. Implement Sci. 2016 Apr 29;11:57 - PubMed
  69. Drug Alcohol Depend. 2006 Jun 28;83(2):122-9 - PubMed
  70. Drug Alcohol Depend. 2017 Mar 01;172:34-42 - PubMed
  71. Psicothema. 2013;25(3):307-12 - PubMed
  72. Am J Drug Alcohol Abuse. 2007;33(6):823-32 - PubMed
  73. Crim Behav Ment Health. 2005;15(4):236-48 - PubMed
  74. Br J Psychiatry. 2012 May;200(5):364-73 - PubMed
  75. Cochrane Database Syst Rev. 2013 Dec 19;(12):CD010862 - PubMed
  76. Cochrane Database Syst Rev. 2014 Jan 02;(1):CD010901 - PubMed
  77. J Addict Dis. 2017 Jan-Mar;36(1):60-71 - PubMed
  78. J Exp Criminol. 2014;10:105-127 - PubMed
  79. Lancet HIV. 2017 Feb;4(2):e59-e66 - PubMed
  80. J Consult Clin Psychol. 2006 Oct;74(5):955-66 - PubMed
  81. Am J Community Psychol. 2013 Mar;51(1-2):114-22 - PubMed
  82. Addiction. 2015 Mar;110(3):479-90 - PubMed
  83. J Stud Alcohol Drugs. 2013 Sep;74(5):770-6 - PubMed
  84. J Subst Abuse Treat. 2016 Jun;65:13-9 - PubMed
  85. Lancet. 2002 Feb 16;359(9306):545-50 - PubMed
  86. Addict Behav. 2015 Dec;51:51-6 - PubMed
  87. Lancet. 2015 Jul 25;386(9991):350-9 - PubMed
  88. PLoS One. 2013 Sep 04;8(9):e72946 - PubMed
  89. Can HIV AIDS Policy Law Rev. 2003 Dec;8(3):48 - PubMed
  90. J Subst Abuse Treat. 2008 Mar;34(2):242-8 - PubMed
  91. J Subst Abuse Treat. 1996 Jan-Feb;13(1):3-11 - PubMed
  92. J Fam Psychol. 2008 Aug;22(4):550-60 - PubMed
  93. J Drug Issues. 2014 Jan;44(1):69-82 - PubMed
  94. J Drug Issues. 2015 Jan;45(1):53-68 - PubMed
  95. Alcohol Alcohol. 2006 May-Jun;41(3):328-35 - PubMed
  96. Psychiatr Serv. 2009 Jun;60(6):761-5 - PubMed
  97. Subst Use Misuse. 2014 Apr;49(5):560-70 - PubMed
  98. Behav Sci Law. 2003;21(4):415-27 - PubMed
  99. Crim Justice Behav. 2014 Apr;41(4):417-432 - PubMed
  100. N Engl J Med. 2016 Mar 31;374(13):1232-42 - PubMed
  101. Contemp Clin Trials. 2014 Nov;39(2):256-68 - PubMed
  102. J Subst Abuse Treat. 2013 Oct;45(4):370-5 - PubMed
  103. Nurs Res. 2015 May-Jun;64(3):177-89 - PubMed
  104. Evid Based Med. 2006 Aug;11(4):112 - PubMed
  105. Addiction. 1998 Apr;93(4):515-32 - PubMed
  106. J Psychiatr Res. 2012 Sep;46(9):1174-83 - PubMed
  107. Int Pharmacopsychiatry. 1975;10(3):157-68 - PubMed
  108. J Offender Rehabil. 2014 Feb 1;53(2):95-115 - PubMed
  109. Drug Alcohol Depend. 2007 Dec 1;91(2-3):220-7 - PubMed
  110. Am J Drug Alcohol Abuse. 2000 Nov;26(4):537-52 - PubMed
  111. J Subst Abuse Treat. 2013 Nov-Dec;45(5):400-8 - PubMed
  112. Addiction. 2017 Aug;112(8):1462-1469 - PubMed
  113. Drug Alcohol Depend. 2010 Sep 1;111(1-2):161-5 - PubMed
  114. Addict Res Theory. 2014 Dec;22(6):463-473 - PubMed
  115. J Correct Health Care. 2009 Jul;15(3):210-21 - PubMed
  116. N Engl J Med. 1969 Jun 19;280(25):1372-5 - PubMed
  117. Trials. 2017 Aug 4;18(1):365 - PubMed
  118. Br J Gen Pract. 2011 Dec;61(593):e772-80 - PubMed
  119. J Consult Clin Psychol. 2010 Dec;78(6):885-97 - PubMed
  120. J Subst Abuse Treat. 2004 Mar;26(2):95-102 - PubMed
  121. Contemp Clin Trials. 2016 May;48:166-72 - PubMed
  122. Drug Alcohol Depend. 2013 Mar 1;128(3):222-9 - PubMed
  123. J Clin Psychol. 2014 Jul;70(7):644-57 - PubMed
  124. Eur Addict Res. 2015;21(4):179-87 - PubMed
  125. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2012 Dec;47(6):298-307 - PubMed
  126. Am J Psychiatry. 2009 Nov;166(11):1269-77 - PubMed
  127. Br J Psychiatry. 2014 Feb;204(2):98-107 - PubMed
  128. Drug Alcohol Depend. 2006 Sep 15;84(2):160-6 - PubMed
  129. Drug Alcohol Rev. 2018 May;37(4):487-498 - PubMed
  130. Addiction. 2003 Aug;98(8):1137-41 - PubMed
  131. BMC Health Serv Res. 2011 Apr 18;11:80 - PubMed
  132. Trials. 2009 Jul 14;10:53 - PubMed
  133. PLoS One. 2011;6(9):e25127 - PubMed
  134. J Subst Abuse Treat. 2016 Sep;68:1-10 - PubMed
  135. Contemp Clin Trials. 2016 Jul;49:21-8 - PubMed
  136. Psychol Rep. 1993 Dec;73(3 Pt 2):1089-90 - PubMed
  137. J Psychoactive Drugs. 1990 Apr-Jun;22(2):197-209 - PubMed
  138. Pers Soc Psychol Bull. 2014 Mar;40(3):334-47 - PubMed
  139. J Consult Clin Psychol. 2016 Mar;84(3):248-58 - PubMed
  140. J Subst Abuse Treat. 2018 Feb;85:45-48 - PubMed
  141. J Consult Clin Psychol. 2006 Feb;74(1):42-54 - PubMed
  142. Lancet Psychiatry. 2016 Sep;3(9):871-81 - PubMed
  143. Addiction. 2000 Nov;95(11):1631-45 - PubMed
  144. J Subst Abuse Treat. 2006 Sep;31(2):203-11 - PubMed
  145. J Exp Criminol. 2017 Mar;13(1):53-77 - PubMed
  146. Addiction. 2017 Mar;112(3):502-515 - PubMed
  147. J Subst Abuse Treat. 2017 Oct;81:66-72 - PubMed
  148. J Clin Psychiatry. 2013 Dec;74(12):1249-55 - PubMed
  149. Drug Alcohol Depend. 2011 Dec 1;119(1-2):64-71 - PubMed
  150. J Clin Psychol. 2017 Oct;73(10):1226-1246 - PubMed
  151. Eval Program Plann. 2012 Feb;35(1):47-53 - PubMed
  152. J Correct Health Care. 2011 Jul;17(3):226-32 - PubMed
  153. J Subst Abuse Treat. 2009 Oct;37(3):277-85 - PubMed
  154. Addiction. 2007 Jul;102(7):1114-21 - PubMed
  155. Drug Alcohol Depend. 2003 Oct 24;72(1):59-65 - PubMed
  156. Crim Justice Behav. 2015 Oct;42(10):1008-1031 - PubMed
  157. Accid Anal Prev. 2013 Apr;53:89-99 - PubMed
  158. J Anxiety Disord. 2012 Oct;26(7):703-10 - PubMed
  159. J Subst Abuse Treat. 2014 Feb;46(2):134-43 - PubMed
  160. Drug Alcohol Depend. 2017 May 1;174:181-191 - PubMed
  161. J Subst Abuse Treat. 2017 Mar;74:54-64 - PubMed
  162. Int J Drug Policy. 2016 Jun;32:70-6 - PubMed
  163. Addiction. 2015 Jun;110(6):1008-14 - PubMed
  164. J Subst Abuse Treat. 2015 Dec;59:52-8 - PubMed
  165. Mindfulness (N Y). 2017 Jun;8(3):603-614 - PubMed
  166. Int J Drug Policy. 2010 Jul;21(4):296-301 - PubMed
  167. Int J Addict. 1994 Aug;29(10):1315-45 - PubMed
  168. BMC Psychiatry. 2016 Dec 7;16(1):436 - PubMed
  169. J Subst Abuse Treat. 1998 Nov-Dec;15(6):535-43 - PubMed
  170. Int J Offender Ther Comp Criminol. 2011 Jun;55(4):587-604 - PubMed
  171. Subst Abuse Treat Prev Policy. 2009 Feb 05;4:1 - PubMed
  172. Nurs Res. 2016 May-Jun;65(3):179-90 - PubMed
  173. Subst Use Misuse. 2014 Apr;49(5):536-46 - PubMed
  174. J Subst Abuse Treat. 2003 Oct;25(3):213-21 - PubMed
  175. J Subst Abuse Treat. 2017 Jun;77:44 - PubMed
  176. Contemp Clin Trials. 2017 Jun;57:98 - PubMed
  177. Contemp Clin Trials. 2016 Nov;51:97 - PubMed
  178. Subst Abus. 2016;37(1):248-54 - PubMed
  179. Drug Alcohol Depend. 2009 Jan 1;99(1-3):222-30 - PubMed
  180. Subst Use Misuse. 2000 Oct-Dec;35(12-14):1967-2009 - PubMed
  181. Psychiatr Serv. 1995 Mar;46(3):233-8 - PubMed
  182. J Consult Clin Psychol. 2016 Mar;84(3):210 - PubMed
  183. J Case Manag. 1997 Fall;6(3):119-26 - PubMed
  184. Subst Use Misuse. 2016 Jun 6;51(7):902-11 - PubMed
  185. AIDS Care. 2014;26(9):1071-9 - PubMed
  186. Subst Abus. 2012;33(1):19-29 - PubMed
  187. J Rural Health. 2017 Jun;33(3):250-256 - PubMed
  188. J Subst Abuse Treat. 2010 Apr;38(3):263-74 - PubMed
  189. Compr Psychiatry. 1977 May-Jun;18(3):211-9 - PubMed
  190. J Subst Abuse Treat. 2014 Mar;46(3):306-14 - PubMed
  191. J Offender Rehabil. 2014;53(7):543-561 - PubMed
  192. Addiction. 2006 Feb;101(2):241-51 - PubMed
  193. Am J Addict. 2016 Apr;25(3):233-40 - PubMed
  194. Addiction. 2015 Dec;110(12):1975-84 - PubMed
  195. Alcohol Treat Q. 2016;34(4):415-424 - PubMed
  196. Contemp Clin Trials. 2015 Mar;41:110-7 - PubMed
  197. Drug Alcohol Depend. 2016 Jan 1;158:38-44 - PubMed
  198. J Subst Abuse Treat. 2012 Apr;42(3):247-59 - PubMed
  199. Psicothema. 2006 Aug;18(3):620-9 - PubMed
  200. Drug Alcohol Rev. 2011 Mar;30(2):188-94 - PubMed
  201. Drug Alcohol Depend. 2014 Sep 1;142:33-40 - PubMed

Publication Types